NOVONESIS B revenue breakdown overview

NOVONESIS B revenue for the last year amounted to 3.60 B CHF, the most of which — 2.03 B CHF — came from its highest performing source at the moment, Planetary Health Biosolutions. The greatest contribution to the revenue figure was made by Rest of Europe, Middle East & Africa — last year it brought NOVONESIS B 1.25 B CHF, and the year before that — 748.13 M CHF.